|
Philipp Diehl1,*, Ferenc Nagy1,*, Verena Sossong1, Thomas Helbing1, Friedhelm Beyersdorf2, Manfred Olschewski3, Christoph Bode1, Martin Moser1
1Department for Cardiology and Angiology, 2Department for Cardiovascular Surgery and 3Department for Biometry and Statistics, University Hospital Freiburg, Freiburg, Germany
The mechanisms of the progression of aortic valve stenosis are unknown.The involvement of mononuclear cells and of chronic systemic inflammation has been suggested by analysis of pathological specimens. We hypothesize that shear stress caused by the constricted aortic orifice contributes to systemic proinflammation by activation of circulating blood cells and thereby generation of microparticles. Using flow cytometry we analyzed 22 patients with severe aortic valve stenosis (AVS) and 18 patient controls for the generation of circulating microparticles from platelet- (PMPs: CD31+/CD61+ or CD62P+), leukocyte- (LMPs: CD11b+) and endothelial cell (EMPs: CD62E+) origin. Apart from the constricted valve orifice groups were similar. PMPs were increased in AVS patients and their number correlated with valvular shear stress. Monocytes were activated in AVS patients, an observation that was also reflected by increased numbers of LMPs and by the detection of PMP-monocyte conjugates. Furthermore, EMPs reflecting the activation of endothelial cells but also conferring systemic inflammatory activity were increased in AVS patients and correlated with the number of activated monocytes. In conclusion, we show that AVS is accompanied by increased levels of microparticles and that shear stress can induce the formation of microparticles.Based on our results and histologic findings of other investigators the speculation that shear stress related to aortic valve stenosis induces a vicious circle including the generation of PMPs, the subsequent activation of monocytes and LMPs and finally the activation of endothelial cells contributing to the progress of aortic valve stenosis appears to be justified.
endothelial activation, microparticles, aortic valve stenosis
| 1. | ||
Leigh A. Madden1, Rebecca V. Vince1, Marie E. Sandström2, Lee Taylor2, Lars McNaughton2, Gerard Laden3 Thrombosis and Haemostasis 2008 99 5: 909-915 http://dx.doi.org/10.1160TH008-01-0030 | ||
| 2. | ||
Denise M. Ray*1, Sherry L. Spinelli*2, Stephen J. Pollock1, Thomas I. Murant1, Jamie J. O’Brien1, Neil Blumberg2, Charles W. Francis3, Mark B. Taubman4, Richard P. Phipps1 Thrombosis and Haemostasis 2008 99 1: 86-95 http://dx.doi.org/10.1160/TH07-05-0328 | ||
| 3. | ||
Mohammed N. Abid Hussein*, Anita N. Böing*, Augueste Sturk, Chi M. Hau, Rienk Nieuwland Thrombosis and Haemostasis 2007 98 5: 1096-1107 http://dx.doi.org/10.1160/TH05-04-0231 | ||